Skip to search formSkip to main contentSkip to account menu

Instenon

Known as: 3,4,5-trimethoxybenzoic acid 1,2-ethanediylbis(methylimino)-3,1-propanediyl) ester mixt. with N,N-diethyl-4-hydroxy-3-methoxybenzamide & 3,7- dihydro-7-(2-hydroxyethyl)-1,3-dimethyl-1H-purine- 2,6-dione 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Instenon, a combined nootropic agent, was used on the step-type basis within a complex treatment of optic nerve atrophy caused by… 
2002
2002
Minimal brain dysfunction (MBD) represents the most common type of neuropsychic disorders in childhood. Resulting in focal… 
2002
2002
The effect of 5 medications used in the treatment of ischemic brain lesions on free radical oxidation was studied. The efficacy… 
1997
1997
Effectiveness of Instenon (Alkaloid Pharm. Co.), the preparation, containing hexobendin, hydroxytheophyllin, etamivan was… 
1997
1997
Effectiveness of Instenon (Alkaloid Pharm. Co.), the preparation, containing hexobendin, hydroxytheophyllin, etamivan was… 
1983
1983
The effect of hexobendine, pentoxifylline and of the combination Instenon, containing hexobendine, on the dynamic viscosity of… 
1975
1975
The distribution of the parameter of asymmetry of the wave fronts in EEG on the convexital surface of the cortex during instenon…